After being fired, I became the light of medicine

Chapter 77 Those who want to participate can give it a try!
Zhang Yang soon received a call from Dean Zhou himself.

Amid Dean Zhou's enthusiastic congratulations, he felt an indescribable feeling in his heart.

25% makes Dean Zhou so excited,
If I increase the curative effect of Afovir to 50% next, I wonder what Dean Zhou’s reaction will be?
It is uncertain how President Zhou will react in the future.

But when the first batch of clinical data of the second phase of the "Ekofovir" clinical trial was released on the National Drug Clinical Trial Website,
Then, after the official "Starlight Project" simultaneously released the latest clinical progress of the "QS-001" project, major pharmaceutical companies were surprised.

"Qingshan Pharmaceutical has made great progress in the treatment of hepatitis B?"

"How come it's so fast? Didn't they barely pass Phase I clinical trials not long ago? And they've achieved significant results in Phase II clinical trials in the past two or three months?"

"This is impossible. I've seen the research and development direction of their new drug before. It's a cytotoxic drug. They made a breakthrough in the blink of an eye. And they can have a 25% cure rate for hepatitis B?!"

All pharmaceutical companies were shocked and confused. No one expected that Qingshan Pharmaceutical would come from behind and actually make a breakthrough!

Among them, Hengrui Medicine was the most shocking.

In the office, Su Wenping stared at the news in front of him with a bitter smile on his face.

In fact, he has already attached enough importance to Qingshan Pharmaceutical!

When Qingshan Pharmaceutical's "QS-001" project just entered the Phase II clinical trial, he immediately began to gain an in-depth understanding of this drug.

Over the past two months, he has roughly figured out the research and development logic of Qingshan Pharmaceutical, but he did not expect that Qingshan Pharmaceutical had achieved major results just as he figured out the drug logic!
"Qingshan Pharmaceutical's speed is too fast!"

Su Wenping's eyes flashed with despair, but the general manager Su Lin beside him comforted him in a deep voice:

"Wenping, it's really amazing that they were able to find an effective compound in such a short time."

"But this is only the first batch of clinical trial data. It is not certain whether the cure rate can be maintained at 25% in the future!"

"We may not have no chance!"

Su Wenping smiled bitterly and shook his head:
"Boss Su, we may not have a chance."

"Based on my understanding of Qingshan Pharmaceutical, they should have newer and more significant results soon!"

Su Lin was stunned.

Just when domestic pharmaceutical companies were surprised, the news also reached the United States and Gilead.

"I have to say that the thinking of this Chinese pharmaceutical company, Qingshan Pharmaceutical, is indeed very novel."

"It enters liver cells in a cytotoxic manner, causing liver cells infected with hepatitis B virus to die quickly, thus achieving the purpose of killing the hepatitis B virus."

"But a 25% cure rate is not good enough. It seems they haven't found the right compound yet."

"John, we have to speed up the process. This Chinese pharmaceutical company may be a strong competitor of ours."

The release of the Phase II clinical trial data of Tsingshan Pharmaceutical's "QS-001" surprised many pharmaceutical companies, but fortunately, the amount of Phase II clinical trial data is currently small, and it is difficult to say whether the cure rate of 25% can be maintained.

Secondly,

Even with a 25% cure rate, coupled with the cytotoxicity of the drug itself, it is highly unlikely to become a true first-line drug.

After the surprise, major pharmaceutical companies felt tremendous pressure and began to pay close attention to the subsequent research and development progress of Tsingshan Pharmaceutical's "QS-001".

The news soon spread to the hepatitis B forum.

Huang Yi, as the moderator of the Hepatitis B forum, is actually not a hepatitis B patient.

but.

After seeing the significant achievements of Qingshan Pharmaceutical's new drug "QS-001" announced by the organizer of the "Starlight Project", he couldn't help but get excited. "Good news! There is a 25% chance of curing hepatitis B!"

"We must move to Hepatitis B as soon as possible, and let everyone see the latest results! Now everyone should have some confidence, right?"

Huang Yi was so excited that he quickly uploaded the post to Tieba, and even gave it an exciting title:

[Good news! The latest hepatitis B drug from domestic pharmaceutical company Qingshan Pharmaceutical has achieved a cure rate of 25% in Phase II clinical trials! ]

This time, as soon as the post was published, the number of views exceeded 200 in just a few minutes. He excitedly refreshed the post, hoping to see the enthusiastic discussion among the forum friends.

However, one minute, five minutes, ten minutes passed, and apart from a few words of "thank you for forwarding" in the post, there was almost no discussion of this matter by any netizens.

Huang Yi was extremely surprised, he started to push the post continuously, hoping that more friends would see this message!
but!

In the next half hour, no matter how hard he tried, only a few people responded!
An hour later, the popularity of the post began to decline and was gradually squeezed out by other posts!

Looking at the situation in front of him, Huang Yi felt extremely lost and confused.

People didn’t pay attention to the “Starlight Project” before because they had no hope and because they had become desperate after repeated disappointments!
And now!
Isn’t hope right before our eyes?

Why are people still so indifferent and indifferent?! Are they even not interested in discussing it?!

Do they really not care anymore?
"Hey!"

Huang Yi sighed heavily.

In the next few days, his posts completely sank, and after being seven or eight pages away from the homepage, they completely lost their popularity.

Not to mention his topic posts, half a year after the launch of the "Starlight Project", all posts about the Starlight Project in the entire Hepatitis B forum almost disappeared.

The posts about the "Starlight Project" and new drugs in the Hepatitis B forum did not seem to make any waves. Under such indifference, the second batch of Phase II clinical trial data of Qingshan Pharmaceutical's "QS-001" was published on the official website without anyone noticing.

The results were almost the same as the last time. There were 15 patients and 8 subjects in this batch, and two of them successfully turned negative, and the cure rate remained stable at 25%.

This time, Huang Yi noticed the official announcement as soon as possible.

After a slight hesitation, he still moved to the hepatitis B bar.

However, compared to the last time, he no longer has too many expectations. He doesn't know what these hepatitis B patients are thinking, or how they view the "Starlight Project" and innovative hepatitis B drugs.

really.

Half an hour after the post was published, the post titled [Qingshan Pharmaceutical Phase II Clinical Data Update: New Drug Still Maintains 25% Cure Rate] still failed to arouse discussion among patients.

Just when he was about to quit the forum in despair, a familiar ID suddenly appeared in the comments.

【The Unrestrained Prodigal Son】:
"The data is true. I just participated in the second batch of clinical trials of Qingshan Pharmaceutical."

"But I'm not cured, I'm 75% of it!"

"Moreover, the side effects of this drug are very strong. I took it for two months and felt weak, nauseous and vomited. I could hardly do anything. My transaminase level was always high, over 200!"

“If you want to participate, you can give it a try!
What I can guarantee is that the 25% cure rate is real!"

What Huang Yi didn’t expect was that not long after this comment was posted, more and more people started discussing the post!
……

PS: Thank you for the 500 coins reward from the reader I am still lonely

(End of this chapter)